Residents with any information have been urged to contact the concerned authority
The UK's health regulator has approved an antibody cocktail developed by Regeneron and Roche to prevent and treat Covid-19, it said on Friday, adding it was trying to roll it out to patients soon.
The Medicines and Healthcare products Regulatory Agency (MHRA) said the drug Ronapreve could help prevent infection, help resolve symptoms of severe Covid-19 infection and reduce the chances of hospitalisation.
"This treatment will be a significant addition to our armoury to tackle Covid-19," British health minister Sajid Javid said in a statement.
Ronapreve can be taken via injection or infusion. It binds tightly to the coronavirus at the lining of the respiratory system and prevents it from gaining access to cells of the respiratory system, the MHRA said.
Ronapreve belongs to a class of drugs called monoclonal antibodies which mimic natural antibodies produced by the body to fight off infections. The drug is not intended to be used as a substitute for vaccination, the MHRA said.
Last month Japan became the first country to approve Ronapreve to treat mild to moderate Covid-19 infections.
Residents with any information have been urged to contact the concerned authority
Northeastern University in Boston says the action was taken after some protesters resorted to virulent anti-Semitic slurs
The church has been built on 4.37 acres of land, and stands opposite the BAPS Hindu temple
A detailed guide on where to apply, the steps involved, and criteria for eligibility
The Emirates called for strengthening the international humanitarian response and providing urgent relief to those in need
Photonics is the study of light and has several applications including LED, VR, holograms, high-speed internet and solar panels among other things
A delegation from Egypt arrived in Israel on Friday hoping to revive the truce negotiations
The decision aims to protect the safety and security of pilgrims